Antiviral activity against influenza A virus A/WSN/33 (H1N1) infected in MDCK cells assessed as reduction in cytopathic effect at 100 uM after 48 hrs by plaque assay
Antiviral activity against influenza A virus A/WSN/33 (H1N1) infected in MDCK cells assessed as reduction in cytopathic effect after 48 hrs by plaque assay
Antiviral activity against influenza A virus A/WSN/33 (H1N1) infected in MDCK cells assessed as nucleoprotein level in infected cells at 0 to 2 hrs virus entry step at 100 uM by Time-of-addition experiment
Antiviral activity against influenza A virus A/WSN/33 (H1N1) infected in MDCK cells assessed as nucleoprotein level in infected cells at 2 to 8 hrs viral genome replication and translation step at 100 uM by Time-of-addition experiment
Antiviral activity against influenza A virus A/WSN/33 (H1N1) infected in MDCK cells assessed as nucleoprotein level in infected cells at 2 to 10 hrs progeny virion release step at 100 uM by Time-of-addition experiment
Inhibition of influenza A virus A/WSN/33 (H1N1) Hemagglutinin transfected in Human HeLa cells assessed as polykaryon formation at 100 uM after 15 mins by by microscopy
Antiviral activity against influenza A virus A/WSN/33 (H1N1) infected in MDCK cells assessed as reduction in plaque formation after 5 passage of multi-passing experiment by microscopy
Inhibition of influenza A virus A/WSN/33 (H1N1) Hemagglutinin 1 binding to sialic acid receptor assessed as response unit at 20 ug/ml by surface plasmon resonance assay
Inhibition of influenza A virus A/WSN/33 (H1N1) Hemagglutinin 1 binding to sialic acid receptor assessed as response unit at 10 ug/ml by surface plasmon resonance assay
Inhibition of influenza A virus A/WSN/33 (H1N1) Hemagglutinin 1 binding to sialic acid receptor assessed as response unit at 5 ug/ml by surface plasmon resonance assay